Cite
HARVARD Citation
Tay, R. et al. (2019). Prognostic value of circulating tumour cells in limited-stage small-cell lung cancer: analysis of the concurrent once-daily versus twice-daily radiotherapy (CONVERT) randomised controlled trial. Annals of oncology. pp. 1114-1120. [Online].